-+ 0.00%
-+ 0.00%
-+ 0.00%

The US Food and Drug Administration approved Isemblyd for the treatment of spinal muscular atrophy in patients 2 years and older.

Zhitongcaijing·09/11/2026 21:25:10
Listen to the news
The US Food and Drug Administration approved Isemblyd for the treatment of spinal muscular atrophy in patients 2 years and older.